mojeIKP app will also include coronavirus test result
1.9 million Poles have already downloaded mojeIKP application, a free mobile application that gives users access to some of the…
1.9 million Poles have already downloaded mojeIKP application, a free mobile application that gives users access to some of the…
Preliminary results from an experimental study of Pfizer’s new drug for Covid-19 are very promising, with an 89% efficacy rate…
The Polish parliament has passed an amendment to the law which will allow for a gradual increase in healthcare spending,…
Israel’s Covid drug EXO-CD24, subjected to Phase II trials in Athens, allowed 29 out of 30 moderate to severe patients to…
The idea is controversial, but there are many indications that such a scenario is feasible. There are also many voices…
Genomtec is not resting on its laurels and presents its next idea. The COVID-19 test from the patient’s saliva is…
BioNTech has announced the establishment of a regional headquarters in Southeast Asia in Singapore. A fully integrated mRNA production facility…
Thanks to the adoption by the Committee for Medicines for Human (CHMP) belonging to the European Medicines Agency (EMA), two…
The increasing number of severe cases of COVID-19 patients is placing a significant burden on medical facilities in Poland. The…
According to the announcement, by the end of August, every willing Polish citizen is to receive the vaccination for COVID-19….
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.